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Diisocyanates are highly reactive chemical compounds widely used in the manufacture of
polyurethanes. Although diisocyanates have been identified as causative agents of allergic
respiratory diseases, the specific mechanism by which these diseases occur is largely
unknown. To better understand the chemical species produced when isocyanates are reacted
with model peptides, tandem mass spectrometry was employed to unambiguously identify
the binding site of four commercially-relevant isocyanates on model peptides. In each case, the
isocyanates react preferentially with the N-terminus of the peptide. No evidence of side-chain/
isocyanate adduct formation exclusive of the N-terminus was observed. However, significant
intra-molecular diisocyanate crosslinking was observed between the N-terminal amine and a
side-chain amine of arginine, when Arg was located within two residues of the N-terminus.
Addition of multiple isocyanates to the peptide occurs via polymerization of the isocyanate at
the N-terminus, rather than via addition of multiple isocyanate molecules to varied residues
within the peptide. The direct observation of isocyanate binding to the N-terminus of peptides
under these experimental conditions is in good agreement with previous studies on the
relative reaction rate of isocyanate with amino acid functional groups. (J Am Soc Mass
Spectrom 2009, 20, 1567–1575) © 2009 Published by Elsevier Inc. on behalf of American Society
for Mass SpectrometryDiisocyanates are highly reactive chemicals widelyutilized in themanufacture of polyurethane prod-ucts, such as fibers, foams, insulation, and au-
tomotive products, including paints and protective
coatings for truck beds. The most widely used isocya-
nates are the diisocyanates methylenebis(phenyl isocya-
nate) (MDI), toluene diisocyanate (TDI) and hexameth-
ylene diisocyanate (HDI). TDI is often utilized in
industrial applications in 80/20 and 65/35 mixtures of
the 2,4- and 2,6-TDI isomers. Globally, TDI accounts for
34% of the isocyanate market [1]. Diisocyanate exposure
results in sensitization and asthma, contact dermatitis,
and hypersensitivity pneumonitis [2]. Diisocyanate-
induced asthma in occupationally exposed worker pop-
ulations is estimated to range from 5% to 30% [2–5]. The
isocyanate (NCO) functional group may react with
water to form amines, with alcohols to form urethanes,
with amines to form ureas, with carboxylic acids to
form amides, and following hydrolysis, with other
isocyanates to form dimers and trimers. Previous stud-
ies [6, 7] present strong evidence that diisocyanates
bind to such proteins as albumin and keratins in the
airway. Furthermore, some occupational tasks, such as
paint mixing/spraying and production of composite
wood products, result in significant diisocyanate der-
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opment of asthma-like symptoms.
Although several protein targets of diisocyanates in
vivo have been identified, the underlying antigenic
forms of the diisocyanate are, as yet, unknown [10–12].
The diverse functional groups present in proteins in-
cluding amines, amides, thiols, alcohols, and carboxylic
acids present a large number of potential reaction sites
for the isocyanate. However, previous studies have
suggested that under physiologic conditions, these are
limited to N-terminal -amines, the sulfhydryl group of
cysteine, the hydroxyl groups of serine and tyrosine, the
-amine of lysine, and the secondary amine of the
imidizole ring of histidine [13].
Tandem mass spectrometry, in particular collision
induced dissociation (CID) of [M  2H]2 ions pro-
duced via electrospray ionization (ESI) [14–17] is a pow-
erful technique for the determination of not only primary
sequence in peptides [18], but also post-translational mod-
ification [15] or chemical adduction. In this study, we have
applied CID on a high-resolution quadrupole time-of-
flight (qTOF) mass spectrometer [19] to characterize the
adducts produced by the reaction of four commercially
available bioactive peptides with four industrially rele-
vant mono- and diisocyanates in an effort to (1) deter-
mine the number, chemical identity, and relative abun-
dance of reaction products observed, and (b) identify
the specific binding site of the isocyanate within the
peptide. In particular, we have studied the adducts
formed by 2,4- and 2,6-TDI because of the widespread
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well-documented health effects. Due to the possibility
of complex reaction products including inter- and
intramolecular crosslinking with the diisocyanates,
we have also evaluated the binding chemistry of the
monoisocyanate analogues of 2,4- and 2,6-TDI, para-
toluene isocyanate (PTI) and ortho-toluene isocya-
nate (OTI).
Experimental
Reagents
Unless otherwise specified, all reagents were acquired
from Sigma-Aldrich (St. Louis, MO, USA) and used
without further purification. Formic acid (99.5%) was of
mass spectrometry grade and acetonitrile and acetone were
HPLC-grade. Ortho-toluene isocyanate (OTI), para-toluene
isocyanate (PTI), 2,4-toluene diisocyanate (2,4-TDI, and
2,6-toluene diisocyanate (2,6-TDI) were dissolved in
HPLC-grade acetone. The peptides leucine-enkephalin
(Leu-enk, YGGFL), angiotensin I (DRVYIHPFHL), Sub-
stance P-amide (RPKPQQFFGLM-NH2), and fibronectin-
Figure 1. Structures of the isomers of toluene isocyanate, toluene
diisocyanate and a hydrolysis product.
Table 1. Relative ion intensities of ortho- and para-toluene isocy
Peptide Sequence
Leu-enk YGGFL
Angiotensin I DRVYIHPFHL
FAPP WQPPRARI
Substance P RPKPQQFFGLM-NH2adhesion promoting peptide (FAPP, WQPPRARI) were
dissolved in 18 M distilled deionized water (DDI)
produced by a Millipore Synthesis A-10 (Billerica,
MA, USA).
Preparation of Isocyanate-Peptide Adducts
Stock peptide solutions were prepared in DDI at a
concentration of 0.5 mg/mL. Solutions of each of the
four isocyanates were freshly prepared in 1 mL HPLC-
grade acetone and infused at a 1:1 mol ratio into each
peptide solution at a rate of 1.2 mL/h using a syringe
pump (model 100; KD Scientific Inc., Holliston, MA,
USA) with constant stirring. Reactions were carried out
at room temperature in a chemical fume hood, and
allowed to stir for 15 min following completion of the
infusion. Peptide-isocyanate adduct solutions were fil-
tered using 0.45 m filters (Millipore, Billerica, MA,
USA) and stored at 20 °C until analysis.
Mass Spectrometry
Aliquots of each peptide adduct solution were diluted
50:1 in 50/50 0.1% formic acid/HPLC-grade acetonitrile,
yielding a final solution concentration of all peptide-
NCO species of 100 pmol/L. Samples were infused
at a rate of 5 L/min to a Micromass QTOF2 (Waters
Corp., Milford, MA, USA) quadrupole time-of-flight
mass spectrometer operated in positive electrospray
(ESI) mode. Sample analysis was performed at a
capillary voltage of 2.5 kV with dry N2 desolvation gas
(NitroFlowLab; Parker Hannifin Corp., Haverhill, MA,
USA) at a flow rate of 400 L/h and a temperature of
150 °C. Ultra High Purity (UHP) Argon was used as a
collision gas at collision energies of 5 eV (MS analysis)
and 25–30 eV (MS/MS analysis). For peptide sequenc-
ing, the doubly charged [M 2H]2 ion was selected by
MS1, with the exception of Leu-enkephalin (the [M 
H] ion was selected). The collision energy was set
independently for each peptide to yield optimal relative
abundance of sequence-specific fragment ions. Post-
acquisition mass spectral charge deconvolution was per-
formed with the “MaxEnt3” algorithm in the ProteinLynx
4.1 software suite (Waters Corp., Milford, MA, USA). The
mass spectrometer was externally calibrated over the
range 70–1570 u using the CID fragment ion mass spec-
trum of [Glu]1-fibrinopeptide B (EGVNDNEEGFFSAR)
[M  2H]2 ions acquired at a collision energy of 35 eV.
e/peptide reaction products
M M  OTI M  PTI
100 4.7 1.3
13 100 18
26 31 100anat0.35 100 32
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MS Analysis of Isocyanate/Peptide Reaction
Products
Four bioactive peptides were chosen for analysis (Leu-enk,
angiotensin I, FAPP, and Substance P-amide) and reacted
with two monoisocyanates (OTI and PTI) and two
diisocyanates (2,4-TDI and 2,6-TDI). Structures and
mass-to-charge data for each of these isocyanates is
presented in Figure 1. The four peptides were chosen
because they contain putative reactive amino acid resi-
dues in varied locations (e.g., N-terminus, internal,
C-terminus). The resulting reaction products were ana-
lyzed by high-resolution qTOF-MS. The relative abun-
dance and accurate mass (20 ppm) of the major
reaction products was measured in qTOF-MS mode and
the identity and relative intensity of the observed
reaction products are listed in Tables 1, 2, and 3. The
only reaction products observed for the monoisocya-
nates OTI and PTI (Table 1) were unreacted peptide
[M  2H]2 and the product formed by addition of
one isocyanate to the peptide [M  NCO  2H]2
(133.0528 u). For Leu-enk, angiotensin I, and Sub-
stance P, the OTI adduct was two to five times more
abundant than the PTI adduct.
The products of the reaction of peptides with the
diisocyanate species 2,4- and 2,6-TDI were significantly
more varied. A number of reaction products were
observed (see Tables 2 and 3) including the anticipated
mono-substituted [M  dNCO*  2H]2 (148.0634 u)
product. (The asterisk (*) indicates the diisocyanate
product that has undergone hydrolysis at one isocya-
nate, see Figure 1). TDI hydrolyzes rapidly to a diamine
in aqueous solution, with a half life of 5 to 30 s [20, 21].
Consequently, the 174.0429 u [M  dNCO  2H]2
adduct is not observed unless the second isocyanate
reacts at another site within the peptide to form an
intramolecularly crosslinked species. In the case of
Substance P, this intramolecular crosslinked species
was the dominant reaction product, whereas it was only
Table 2. Relative ion intensities of 2,4-toluene diisocyanate/pep
Peptide Sequence M
Leu-enk YGGFL 100
Angiotensin I DRVYIHPFHL 83
FAPP WQPPRARI 100
Substance P RPKPQQFFGLM-NH2 33
*Hydrolysis product (amine group at either position 2 or 4).
Table 3. Relative ion intensities of 2,6-toluene diisocyanate/pep
Peptide Sequence M
Leu-enk YGGFL 100
Angiotensin I DRVYIHPFHL 40
FAPP WQPPRARI 100
Substance P RPKPQQFFGLM-NH2 6.2*Hydrolysis product (amine group at either position 2 or 4).a minor reaction product (ca. 30% relative abundance)
for angiotensin I. Intramolecular crosslinking is not
observed for leu-enk or FAPP, neither of which has
residues with side-chain amines near the N-terminus.
Adduction of two hydrolyzed TDI molecules, [M 
2dNCO*  2H]2, was observed in low relative abun-
dance, as was intermolecular crosslinking of two pep-
tides via TDI, [2M  dNCO  2H]2. Sabbioni and
coworkers [13] suggested in 2001 that both isocyanate
moieties of a diisocyanate would not react at the same
time with one or more proteins (e.g., formation of [M 
dNCO  2H]2 and [2M  dNCO  2H]2 should not
be observed). However, under the conditions employed
here, these products are formed, and in the case of
Substance P, such crosslinking represents the dominant
reaction product(s).
Addition of a second TDI molecule to the peptide is
the result of polymerization of two diisocyanates to
form a dimer bound to the peptide, rather than binding
of two dNCOs to two different amino acid residues
(e.g., side-chain adduction). This was determined on
the basis of CID data (described below), as well as the
observation of two TDI molecules bound to Leu-
enkephalin, which has only one putative binding site,
the N-terminal primary amine.
In general, we observe that isocyanates at the 2-
position (OTI and 2,6-TDI) are far more abundant
adducts than those at the 4-position (PTI and 2,4-TDI)
under the aqueous conditions employed for this study.
Although the isocyanate in the 4-position is roughly
four times more reactive than that in the 2-position
toward alcohols (during polyurethane production) the
2-position is more reactive toward amines, in good
agreement with our observations [1, 22]. A comparison
of the relative reactivity of the peptides with isocya-
nates is difficult to make as the pH of non-buffered
aqueous solutions will vary with the chemical nature of
the peptide dissolved. Although current investigations
into the effect of pH on isocyanate-peptide binding are
underway in our laboratory, previous studies have dem-
reaction products
TDI* M  TDI M  2TDI* 2M  TDI
3.4 — 0.89 —
00 29 47 23
13 — 5.5 9.4
17 100 9.6 50
reaction products
 TDI* M  TDI M  2TDI* 2M  TDI
3.7 — 0.11 —
100 5.2 30 18
14 — 4 4.7
29 100 11 18tide
M 
1tide
M
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act as competing nucleophiles in this system [23].
Tandem MS Analysis of Isocyanate-Peptide
Adducts
To determine the isocyanate binding site, each peptide
and its isocyanate adduct(s) was selected for sequenc-
ing by tandem mass spectrometry utilizing Ar collision-
induced dissociation in the qTOF mass spectrometer.
The MS/MS spectrum of each peptide and its corre-
sponding isocyanate adducts are presented in Figures 2,
3, 4, 5, and 6. For each peptide, the tandem mass spectra
of the monoisocyanate adducts (OTI and PTI) and the
diisocyanate adducts (2,4- and 2,6-TDI) were very sim-
ilar in terms of m/z and relative abundance of the
Figure 2. Selected tandem mass spectra for Le
([M  H] m/z  556.2766); (b) PTI adduct ([M 
m/z  704.3400).observed fragment ions. For simplicity, only the frag-
ment ion spectra of the PTI and 2,4-TDI adducts are
presented here. The fragment ion mass spectra of the
OTI and 2,6-TDI adducts may be found in the Support-
ing Information, which can be found in the electronic
version of this article.
Figure 2 presents the CID fragment ion mass spectra
for Leucine-enkephalin (YGGFL) and the adducts pro-
duced by reaction with PTI and 2,4-TDI. The tandem
mass spectrum of unmodified Leu-enk (Figure 2a) is
characterized by abundant a- and b-type fragment ions
indicative of N-terminal charge retention. A few low
abundance y-type ions, indicative of C-terminal charge
retention, are observed. Similarly, the fragment ion
mass spectra of the peptide-isocyanate adducts (Figure
2b and c) are characterized by abundant N-terminal
-enkephalin (YGGFL). (a) Unmodified peptide
m/z  689.3294); (c) 2,4-TDI adduct ([M  H]ucine
H]
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fragment ion spectrum is of the type [b1  NCO]

(denoted b1*), which provides direct evidence that the
isocyanate is bound to the N-terminal tyrosine of the
peptide. Furthermore, tyrosine is the only immonium ion
observed bound to the isocyanate. These immonium-
isocyanate ions are useful because they provide direct
evidence of isocyanate bound to a specific residue. A
complete set of low abundance yn
 ions are observed;
however, no ions of the type [ynNCO]
 are observed,
providing strong evidence that NCO is exclusively
bound to the N-terminal tyrosine. Loss of PTI and
2,4-TDI are observed from a-, b-, and immonium ions,
indicating that the urea bond formed when the isocya-
nate binds to the N-terminus is labile under CID
Figure 3. Selected tandem mass spectra for an
([M  2H]2 m/z  648.8463); (b) PTI adduct ([M
2H]2 m/z  722.8781).conditions. Because of this, we cannot rule out lowabundance binding of NCO to other sites than the
N-terminus, however, the spectra shown herein
present no evidence of such binding. A complemen-
tary nonergodic fragmentation methodology, such as
electron capture dissociation (ECD) [24], could help
clarify this issue by reducing small molecule losses
from peptide ions, but is not available on qTOF MS
instrumentation.
The CID tandem mass spectra of angiotensin I
(DRVYIHPFHL) and its PTI and 2,4-TDI adducts are
presented in Figure 3. The tandemmass spectrum of the
angiotensin I [M  2H]2 ion (Figure 3a) shows abun-
dant fragmentation with both N- and C-terminal charge
retention, particularly for fragment ions containing his-
tidine (e.g., y2 and y4). The tandem mass spectra of the
nsin I (DRVYIHPFHL). (a) Unmodified peptide
H]2 m/z  715.3728); (c) 2,4-TDI adduct ([M giote
 2isocyanate adducts (Figure 3b and c) yield complete
.1572 HETTICK ET AL. J Am Soc Mass Spectrom 2009, 20, 1567–1575sequence information, demonstrating that the isocya-
nate has bound to the N-terminal aspartic acid residue.
Isocyanate is not observed bound to any C-terminal
(y-type) fragment ions, nor is it observed bound to the
histidine immonium ion. Observation of the prominent
y2 ion and lack of the [y2  NCO]
 fragment ion
suggests that neither the secondary amine on the side
chain of histidine nor the C-terminus is reactive with
isocyanate under these conditions. We conclude that
isocyanate is bound to the N-terminal amine rather
than the side-chain carboxylic acid of the N-terminal
aspartic acid because no C-terminal binding of the
isocyanate is observed in this or any other tandem
mass spectra. The pKa of the aspartic acid side chain
is similar to C-terminal carboxylic acids, both of
which should be deprotonated at non-acid pH, and
therefore would be expected to have similar reactiv-
Figure 4. Selected tandem mass spectra for fib
(a) Unmodified peptide ([M  2H]2 m/z  512
(c) 2,4-TDI adduct ([M  2H]2 m/z  586.3280ity toward isocyanates.For all four peptides examined in this study, we
observe the apparent adduction of two TDI molecules
(296.1468 u). To determine the binding site of the
second TDI molecule, CID was performed on the [M 
2TDI*  2H]2 ion of angiotensin I (supporting data).
The tandem mass spectrum (in particular, observation
of the y9 ion) unambiguously identifies the binding site
of the second TDI molecule as the N-terminus. This
suggests that one isocyanate group of TDI binds to the
N-terminus and the second isocyanate group is hydro-
lyzed to the amine, which then reacts with a second TDI
molecule. Thus, the two TDI molecules are polymerized
at the N-terminus, rather than bound to two separate
locations within the peptide.
Figure 4 presents the CID tandem mass spectra for
fibronectin adhesion promoting peptide (WQPPRARI)
and its PTI and 2,4-TDI adducts. The tandem mass
tin adhesion promoting peptide (WQPPRARI).
); (b) PTI adduct ([M  2H]2 m/z  578.8227);ronec
.2960spectrum of the FAPP [M  2H]2 ion (Figure 4a)
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terminal charge retention. This is not an unexpected
result, given the strongly basic residue arginine at
positions 5 and 7 within the peptide. Abundant loss of
NH3 from fragment ions is observed, consistent with
the tandem mass spectra of other peptides containing
Arg, Lys, Gln, and Asn. In addition, a strong [b7 
H2O]
 ion is observed, as has been well documented for
peptides with non-C-terminal protonated side-chain
residues, such as Arg, Lys, and His [25]. From the
tandem mass spectrometry data (Figure 4b and c), the
isocyanate adduct may be unambiguously assigned to
the N-terminal tryptophan residue. No ions of the type
[ynNCO]
 are observed, in particular, the lack of [y2
NCO] and [y4  NCO]
 ions suggests that the isocya-
nate does not react with the side-chain amine of the
arginine residues. Further evidence of binding to the N-
Figure 5. Selected tandem mass spectra for Sub
ified peptide ([M  2H]2 m/z  674.3713); (b) P
adduct ([M  2H]2 m/z  748.4034).terminus is obtained through the observation of the[Y  NCO] immonium ion and an unusual b1 ion.
Formation of acylium b1 ions is generally considered to
result in the loss of CO to form the stable a1 immonium
ion, however, a number of reports have described the
formation of stable cyclic b1 ions [26, 27].
The tandem mass spectrometry data for Substance P
amide (RPKPQQFFGLM-NH2) and its PTI and 2,4-TDI
adducts are presented in Figure 5. Fragmentation of the
[M  2H]2 ion (Figure 5a) is characterized by abun-
dant a- and b-type ions, internal fragment ions contain-
ing lysine, and loss of NH3. C-terminal y-type ions are
observed in low relative abundance. The isocyanate
adducts are localized to the N-terminal arginine residue
(Figure 5b and c), as evidenced by [a1NCO]
 and [b1
NCO] fragment ions. No [ynNCO]
 ions are observed.
Of particular note, [y9NCO]
 (Lys-containing) and [y1
NCO] (C-terminal Met amide-containing) ions are ab-
e P-amide (RPKPQQFFGLM-NH2). (a) Unmod-
dduct ([M  2H]2 m/z  740.8981); (c) 2,4-TDIstanc
TI asent, suggesting no isocyanate adduction at either the
1574 HETTICK ET AL. J Am Soc Mass Spectrom 2009, 20, 1567–1575C-terminal amide or the lysine side-chain at position 3.
The most abundant product of the reaction of diisocya-
nates (2,4-TDI and 2,6-TDI) with Substance P is the
[M  dNCO  2H]2 ( 174.0429 u) adduct resulting
from intramolecular crosslinking. The CID fragment ion
spectrum of this ion is presented in Figure 6. The dNCO
adduct from the diisocyanate is located on the N-
terminal arginine, presumably bound to the N-terminus
and an amine on the side chain of arginine. Similarly, a
174 u adduct is observed for the reaction of angiotensin
I (which has an arginine at position 2) with diisocya-
nates (see Tables 2 and 3), although this adduct is
observed in low relative abundance. Intramolecular
crosslinking via diisocyanates with arginine residues
further removed from the N-terminus (FAPP has argi-
nine at positions 5 and 7) is not observed. We interpret
this data in aggregate to indicate the diisocyanate
rapidly binds to the N-terminal amine and may subse-
quently react with a side-chain amine of a residue in
close proximity. We interpret the relative abundance of
these products to indicate that the kinetics of the
subsequent side-chain reaction are fast with respect to
hydrolysis if the arginine is at position 1, but slow
relative to hydrolysis if the arginine is removed to
position 2.
Taken as a whole, the present experiments support
the findings of Stark [28], who found that the rate of
reaction of isocyanates with amino groups is related
linearly to pKa. That work suggested that at pH 7 and
below, the N-terminus of peptides and proteins would
react100 times faster than the NH2 group of lysine.
Furthermore, Stark suggested the reaction proceeds via
the uncharged NH2 species, rather than the NH3

ion. The tandemmass spectrometry data presented here
supports this hypothesis, as the isocyanate is observed
bound preferentially to the N-terminal amine in each
peptide. Similarly, Mason and Liebler [29] used phenyl
isocyanate at pH 8.0 to label the N-termini of peptides
generated by proteolytic digests. Other reports [13, 30]
have suggested that the N-terminus of proteins (partic-
Figure 6. Tandem mass spectrum for Substanc
([M  2H]2 m/z  761.3931).ularly albumin and hemoglobin) is the potential site ofdiisocyanate adduction, and the results presented here
demonstrate conclusively, on the basis of tandem mass
spectrometry data, that the N-terminal -amine of these
four model peptides is the site of adduction.
Conclusions
Analysis of peptide-isocyanate adducts by tandem
mass spectrometry reveals that isocyanates bind pref-
erentially to the N-terminus of the four peptides exam-
ined under the conditions employed herein. When a
peptide with an N-terminal residue containing a side-
chain amine is reacted with a diisocyanate, intramolec-
ular crosslinking with the second isocyanate becomes
competitive with hydrolysis, however, the reactivity
decreases as the residue is displaced further from the
N-terminus. When the isocyanate–peptide reaction is
carried out under 1:1 stoichiometric conditions, the
extent of reaction depends on both the choice of isocya-
nate and peptide. In general, the isocyanate in the ortho
position seems to be more reactive than that in the para
position. The results of this study, when taken in
aggregate with those of previous studies, indicate the
N-terminus of proteins is a likely target for adduction in
isocyanate-exposed individuals.
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